Loading...
OTCMHTLZF
Market cap233mUSD
Dec 02, Last price  
1.59USD
Name

Hamilton Thorne Ltd

Chart & Performance

D1W1MN
OTCM:HTLZF chart
P/E
P/S
3.47
EPS
Div Yield, %
0.00%
Shrs. gr., 5y
3.18%
Rev. gr., 5y
18.14%
Revenues
67m
+20.32%
34,03424,7344,794,6936,200,4307,159,1626,326,0067,477,2978,707,6479,033,85810,514,80322,121,06629,213,81435,358,40939,777,88652,352,78855,872,89567,225,476
Net income
-607k
L
00-1,674,935-1,843,263-1,891,620-1,638,330125,155856,3021,027,534678,9475,706,7102,960,355793,275971,2352,434,1011,910,594-607,022
CFO
4m
+130.57%
00-646,177-1,684,958-1,865,027-808,211225,957667,1631,055,025990,4563,243,9004,307,2136,378,6055,939,3255,605,4871,728,2223,984,828
Earnings
Mar 25, 2025

Profile

Hamilton Thorne Ltd. develops, manufactures, and sells precision instruments, consumables, software, and services for the assisted reproductive technologies (ART), research, and cell biology markets. It offers precision laser systems, imaging systems, and other equipment and consumables for the ART and developmental biology research markets under the Hamilton Thorne brand; test laboratory and endotoxin testing services, as well as sperm assays, including Sperm Motility Index and Sperm Penetration; and fresh and cryopreserved mouse embryos supply, and technician training and proficiency testing services under the Embryotech brand. The company also manufactures and distributes products for reproductive medicine, including clinical and laboratory equipment and disposables, as well as complete installations of ART clinics under the Gynemed brand; and bench top incubators, programmable freezers, loggers, alarms, cryo storage, and software systems and sensors for the safe preservation of medical and biological specimens used in ART and cell biology applications under the Planer brand. It sells its products and services through a direct sales force in the United States, Germany, France, and the United Kingdom, as well as through distributors to approximately 2,000 fertility clinics, hospitals, pharmaceutical companies, biotechnology companies, educational institutions, and other commercial and academic research establishments in approximately 75 countries. The company is headquartered in Beverly, Massachusetts.
IPO date
Jul 10, 2007
Employees
Domiciled in
US
Incorporated in
CA

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
67,225
20.32%
55,873
6.72%
Cost of revenue
66,498
54,588
Unusual Expense (Income)
NOPBT
728
1,285
NOPBT Margin
1.08%
2.30%
Operating Taxes
(503)
85
Tax Rate
6.62%
NOPAT
1,230
1,200
Net income
(607)
-131.77%
1,911
-21.51%
Dividends
Dividend yield
Proceeds from repurchase of equity
453
363
BB yield
Debt
Debt current
5,895
4,099
Long-term debt
28,418
13,762
Deferred revenue
2,637
Other long-term liabilities
231
271
Net debt
24,510
859
Cash flow
Cash from operating activities
3,985
1,728
CAPEX
(2,378)
(2,730)
Cash from investing activities
(17,497)
(9,868)
Cash from financing activities
6,320
6,935
FCF
(5,733)
(3,603)
Balance
Cash
9,735
16,666
Long term investments
69
336
Excess cash
6,442
14,208
Stockholders' equity
55,395
46,791
Invested Capital
86,394
59,644
ROIC
1.68%
2.20%
ROCE
0.74%
1.65%
EV
Common stock shares outstanding
147,423
147,640
Price
Market cap
EV
EBITDA
5,986
4,882
EV/EBITDA
Interest
1,373
434
Interest/NOPBT
188.65%
33.77%